Sequencing technology has evolved at such a rapid pace in the decade since
the human genome was first sequenced that what initially took 13 years to
accomplish can now be done in a matter of days. With these technological
advances and the comparable decline in cost, genomics technologies are beginning
to be incorporated into clinic practice.
Already, genetic and genomic tests are
used to assess the risk of breast and ovarian cancer, diagnose diseases such as
cystic fibrosis and Proteus syndrome, and identify the best treatment options
for various cancers, and it is expected that the number of healthcare
applications will only continue to grow. Given the rapid technological
advances, the potential effect on patients’ lives, and the increasing use of
genomic information in clinical care, it is important to evaluate how genomics
data can best be integrated into the clinical setting in order to maximize
patient benefit.
On July 19, 2011, the IOM’s Roundtable on Translating Genomic-Based Research
for Health hosted a workshop to highlight and identify the challenges and
opportunities in integrating large-scale genomic information into clinical
practice. Challenges range from the analysis, interpretation, and delivery of
genetic information to associated workforce, ethical, and legal issues.
Additionally, many patients and providers have yet to realize the broad effect
genomic discoveries are likely to have on treatment and health. The main
objective of the workshop was to start a discussion on what needs to be done to
prepare the necessary infrastructure and to address the various challenges for
realizing genomic medicine. This document summarizes the workshop.
Released: November 11, 2011.Type: Workshop Summary.Topics: Biomedical and Health Research, Public Health.Activity: Roundtable on Translating Genomic-Based Research for Health. Board: Board on Health Sciences Policy
No comments:
Post a Comment
prueba